Absolutely! Regarding BP, here's a nice $$$ commentary about Remdesivir:

Manufactured by Gilead Sciences, one of the world’s largest pharmaceutical companies, Remdesivir costs $3,000 a dose. It is the only anti-viral
treatment for hospitalized COVID-19 patients approved by the NIH COVID-19 Treatment Guidelines Panel, and as a result is a standard of COVID-19 care in many
hospitals, even though many doctors say it doesn’t work, and the WHO recommends against it. It has been shown in studies to have no mortality benefit for COVID-19
patients. (Coincidentally, seven members of the NIH COVID-19 Treatment Guidelines Panel acknowledge in financial disclosures that they have received research support or consultant payments from Gilead, or sit on the advisory board of the $60 billion company). As the Washington Post reported, “Remdesivir may not cure coronovirus, but it’s on track to make billions for Gilead.”

The longer they can keep stalling us, the more they all can make! Wonder if Pfizer  trembles at the thought of competing against us, or is the game plan that they will  just outbid everybody else when they know the jig is up?